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Abstract
Computational methods for image-based profiling are under active development, but their success hinges on assays
that can capture a wide range of phenotypes. We have developed a multiplex cytological profiling assay that “paints
the cell” with as many fluorescent markers as possible without compromising our ability to extract rich, quantitative
profiles in high throughput. The assay detects seven major cellular components. In a pilot screen of bioactive
compounds, the assay detected a range of cellular phenotypes and it clustered compounds with similar  annotated
protein targets or chemical structure based on cytological profiles. The results demonstrate that the assay captures
subtle patterns in the combination of morphological labels, thereby detecting the effects of chemical compounds even
though their targets are not stained directly. This image-based assay provides an unbiased approach to characterize
compound- and disease-associated cell states to support future probe discovery.
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Introduction
Gene-expression profiling, the most established unbiased
profiling method, has been used to support small-molecule
discovery in number of ways. For example, gene expression
has been used to define disease states, such as those caused
by genomic alterations in cancer, thereby enabling
identification of compounds that reverse the cellular phenotype
to a preferable state [1]. Gene expression has also been used
to infer compound mechanism of action by revealing that
previously unconnected compounds yield similar profiles in
cells, or by revealing that sets of genes enriched for those
having specific functions are regulated in a concerted manner
[2,3]. Microscopy images of cells are increasingly being used
for profiling [4,5] because they contain a large amount of
quantitative information about a wide range of complex
phenotypes, and because image-based assays can be scaled
to medium and high throughput with relative ease. It has for
some time been possible to measure hundreds of properties of
individual cells in microscopy images [6] and to find nonlinear
combinations of features that can identify complex phenotypes
[7]. Computational methods for image-based profiling are under
active development [8-13], but have largely been applied to
assays that model particular phenotypes of interest with
minimal numbers of labels. Applying these methods in a more
unbiased manner to, for example, discover new phenotypes of
interest, requires development of an assay that can capture a
much wider range of phenotypes.
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Results
We sought to develop an assay that “paints the cell” with as
many fluorescent morphological labels as possible without
compromising our ability to extract quantitative image-based
profiles in high throughput. We present a multiplex cytological
profiling assay that allows detection of seven major cell
components (Figure 1A), and we demonstrate its ability to
capture a wide range of cellular phenotypes induced by small
molecules (Figure 1B). Further, we demonstrate the ability of
the profiling data to connect compounds with similar
mechanisms of action (Figure 2). Because the profiles capture
subtle patterns in the combination of morphological labels, the
assay can detect the effects of chemical compounds even
though their targets are not stained directly.
We considered only well-characterized, fluorescent, non-
antibody dyes suitable for high-throughput application. We first
screened a number of potential dyes for those with high signal,
low background, assay buffer compatibility, fixation and
permeabilization condition compatibility, staining time, and
optical spectra. To ensure compatibility with commonly
available microscopes, we limited the protocol to detecting
stains in five channels. Within that constraint, we increased the
degree of multiplexing by including two dyes for a given optimal
spectrum if they stained spatially distinct cellular components
that could be distinguished during analysis. The staining
protocol was optimized largely based on qualitative
assessment of cellular features of interest. Particular attention
was paid to the relative concentration of WGA and phalloidin to
allow visualization of the Golgi apparatus, but not at the
expense of detection of actin filaments. Pilot plates were
assayed with varying concentrations of WGA and phalloidin.
Images were examined by eye to select the optimal
concentrations.
The final protocol involves imaging five channels to detect
seven cell components using six stains (Table 1, Figure 1A),
which were significantly optimized for dye concentration, buffer
composition, staining time, and permeabilization, blocking, and
washing conditions. The protocol is readily transferable to
multiple adherent cell lines (Figure S1).
We validated the assay by profiling 1600 commercially
available bioactive compounds (Table S1) spanning a range of
mechanisms of action. Briefly, U2OS cells were plated in
quadruplicate in 384-well plates, incubated for 24 h to allow
cells to adhere and resume growth, and then treated with
compounds for 48 h (typical concentration 10 µM). Following
the multiplex cytological profiling protocol, images were
captured at 20x magnification with an automated epifluorescent
microscope. We extracted 824 morphological features (Table
S2) from each cell using the open-source software CellProfiler
[6]. A number of cellular phenotypes could be detected by eye
(Figure 1B). The profiles of the 64 mock-treated wells on each
plate vary little over the course of the experiment (Figure S2,
Table S3), although some positional effects are evident (Figure
S3, Table S4). Roughly half of the features showed significant
response to one or more compounds (Figure S4). The group of
Figure 1.  The cell-painting assay applied to U2OS cells.  (A) Cells labeled with Hoechst 33342 (nuclei, blue), concanavalin A
(ER), SYTO 14 (nucleoli), phalloidin (actin), WGA (Golgi), MitoTracker Deep Red (mitochondria). Scale bars 50 µm. (B) Ten diverse
phenotypes in compound-treated U2OS cells: toroid nuclei (amperozide); giant, multinucleated cells (fenbendazole); abundant ER
(tetrandrine); redistribution of ER to one side of nucleus (NPPB); reduced nucleolar size (rapamycin); large, flat nucleoli (etoposide);
bright, abundant Golgi staining (Ca-074-Me); actin breaks (latrunculin B); extensive mitochondrial fission (Beta-dihydrorotenone);
and redistribution of mitochondria (berberine chloride). Scale bars 50 μm.
doi: 10.1371/journal.pone.0080999.g001
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Figure 2.  Hierarchical clustering of image-based profiles.  Details are shown for three of the clusters that were highly enriched
for annotation terms. These enriched clusters contain compounds with similar mechanisms of action, some with similar and some
with distinct chemical structure. The presence of these enriched clusters indicates that the assay can identify subtle, physiologically
relevant effects of compounds on cultured cells. U2OS cells labeled for nuclei (blue), ER (green), nucleoli (grey), actin and Golgi
(yellow), and mitochondria (red). Scale bars 50 µm.
doi: 10.1371/journal.pone.0080999.g002
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features that were the least useful for this assay were the
Zernike shape features (Table S5).
To determine whether image-based profiles derived from the
multiplex assay are useful for studying compound mechanism-
of-action, we examined whether clustering compounds
according to image-based profile similarity would group
compounds with similar annotated protein targets or chemical
structure. After clustering hierarchically the 75 active
compounds for which we had annotations and ranking the
clusters' enrichment of annotation terms, we found that several
of the most enriched clusters were convincing mechanistic
groups (Figure 2). For example, cluster A contains both
structurally related and distinct modulators of tubulin
(fenbendazole; oxibendazole; taxol), which lead to large
multinucleated cells with fused nucleoli. The promotion of
polyploidization and multinucleation by tubulin modulators has
been long recognized [14,15]. Cluster B contains modulators of
neuronal receptors, all of which lead to enhanced Golgi
staining and some cells with fused nucleoli: fluphenazine (D1
and D2 dopamine receptor antagonist), metoclopramide (D2
dopamine antagonist; muscarinic M1 receptor antagonist; 5-
hydroxytramine 4 receptor agonist), as well as procaine
(sodium channel antagonist), a structural analog of
metaclopramide (DrugBank [16] acc. DB01233). It is worth
noting that all three compounds contain a basic tertiary amine,
which has been linked to compound accumulation in acidic
cellular compartments, such as the lysosome and Golgi, with
effects on their shape and function [17]. It is possible that this
chemical feature and cellular mechanism underlie the shared
effect of these compounds on morphology rather than channel
inhibition. Cluster C contains a number of structurally related
cardenolide glycosides (digoxin; lanatoside C; peruvoside;
neriifolin; digitoxin), characterized by reduced cell size,
condensed nuclei, plasma membrane blebbing, reduced
nucleolar staining, and significant cytotoxicity (Text S2). While
compounds of this class are thought to affect a range of
biological processes, their effects on morphology are
consistent with their reported ability to cause cell death [18,19].
Discussion
A rich multiplex assay, such as our cell-painting assay, is a
necessary step towards productively profiling a large collection
of small molecules. Profiles from such an experiment could be
mined to identify regulators of dozens of different phenotypes
without having to design and optimize specific assays for each
phenotype. Rather, a large, unbiased profiling experiment
could be performed once and then efficiently and inexpensively
mined for multiple patterns, including unexpected patterns
associated with a perturbation of interest. The rich patterns in
the profiles could also be used to group small molecules based
on their similarity to generate hypotheses about which small
molecules share a common mechanisms of action.
Cellular morphology is affected by a number of factors, such
as the genetic and epigenetic state of the cell, physiologic
processes such as cell division or metabolism, and changes in
environmental cues that alter cell signaling. Extensive
measurement of morphological features, treated as a profile,
can be applied to study the response of cells to diverse
perturbations or to characterize the differences between cells
from disease and non-disease states. The multiplex assay
described here increases the number of morphological features
that can be quantified by microscopy and image analysis to
create image-based profiles. We anticipate the assay will be
useful for characterizing perturbations whose effects are poorly
understood, such as novel small molecules or disease-
associated variants emerging in genome-wide association
studies. We provide the complete set of images from our
experiment as well as source code for computer programs that
reproduce our results (Text S1).
Materials and Methods
Plating
U2OS cells (#HTB-96, ATCC) were plated at the density of
1500–2000 cells per well in 384-well imager quality black/clear
plates (Aurora Biotechnologies/Nexus Biosystems) in 50 µL
DMEM supplemented with 10% fetal bovine serum, and 1%
penicillin/streptomycin. Cells were grown for 24 h at 37°C.
Compound Pinning
Compounds were pin-transferred to cells using a CyBi-Well
robot (CyBio, Inc.). Cells were treated for 48 h at 37°C.
Staining
The samples were stained as follows.
Step 1: MitoTracker and Wheat Germ Agglutinin
staining.  MitoTracker Deep Red (#M22426, Invitrogen) was
dissolved in DMSO to 1 mM. Wheat Germ Agglutinin (WGA)
Alexa594 conjugate (#W11262, Invitrogen) was dissolved in
dH2O to 1 mg/mL. A 500 nM MitoTracker, 60 µg/mL WGA
Table 1. Multiplex cytological profiling assay components.
Cellular component(s) Stain Detection (ex/em)
nucleus Hoechst 33342 387/447 nm
endoplasmic reticulum concanavalin A (con A) AlexaFluor488 conjugate 472/520 nm
nucleoli SYTO 14 green fluorescent nucleic acid stain 531/593 nm
Golgi apparatus and plasma membrane wheat germ agglutinin (WGA) AlexaFluor594 conjugate 562/642 nm
F-actin phalloidin AlexaFluor594 conjugate 562/642 nm
mitochondria MitoTracker Deep Red 628/692 nm
doi: 10.1371/journal.pone.0080999.t001
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solution was prepared in prewarmed media (DMEM, 10% FBS,
1% penicillin/streptomycin). Media was removed from plates;
residual volume was 10 µL in each well. 30 µL of staining
solution was added to wells and incubated for 30 min at 37 °C.
Step 2: Fixation.  10 µL of 16% methanol-free
paraformaldehyde (#15710-S, Electron Microscopy Services)
was added to wells for a final concentration of 3.2%. The plates
were then incubated at room temperature for 20 min. Wells
were washed once with 70 µL 1xHBSS (#14065-056,
Invitrogen).
Step 3: Permeabilization.  A 0.1% solution of Triton X-100
(T8787-100mL, Sigma) was prepared in 1x HBSS. 30 µL of the
solution was added to the wells and incubated for 10–20 min.
Wells were washed twice with 70 µL 1x HBSS.
Step 4: Phalloidin, ConcanavalinA, Hoechst, and SYTO
14 staining.  Concanavalin A Alexa488 conjugate (#C11252,
Invitrogen) was dissolved to 1 mg/mL in 0.1 M sodium
bicarbonate (SH30033.01, HyClone), and Phalloidin Alexa594
conjugate (#A12381, Invitrogen) was dissolved in 1.5 mL
methanol (67-56-1, BDH) per vial. A 0.025 µL phalloidin/µL
solution, 100 µg/mL ConcanavalinA, 5 µg/mL Hoechst33342
(#H3570, Invitrogen), and 3 µM SYTO14 green fluorescent
nucleic acid stain (#S7576, Invitrogen) solution was prepared in
1x HBSS, 1% BSA. 30 µL of staining solution was added to
wells and incubated for 30 min. Wells were washed three times
with 70 µL 1xHBSS, no final aspiration. Plates were sealed with
blue Remp thermal seal, at 171 °C for 4 s.
Imaging
Images were captured at 20x magnification in 5 fluorescent
channels, DAPI (387/447 nm), GFP (472/520 nm), Cy3
(531/593 nm), TexasRed (562/642 nm), Cy5 (628/692 nm) on
an ImageXpress Micro epifluorescent microscope (Molecular
Devices), 9 sites per well, with laser based autofocus in the
DAPI channel, first site of each well.
Image analysis
Version 2.0.9925 of the image-analysis software CellProfiler
[6] was used to locate and segment the cells and measure
many features of each cell (Table S2) using the pipelines
provided (Text S1). After correcting for uneven illumination, the
pipeline identifies the nuclei from the DAPI channel and uses
the nuclei as seeds to help a segmentation algorithm identify
the cytoplasm[20,21]. The pipeline measure size, shape,
texture, intensity statistics, and local density of the nuclei,
cytoplasms, and entire cells.
Annotation
We used annotations that have previously been collected
and curated over the course of several projects. Many of the
annotations have been deposited into ChemBank [22], but the
annotation work has continued after ChemBank became static.
The annotations we used are included as supplementary data.
The annotations covered 649 of the 1600 compounds in the
experiment (Table S6). Some annotations were from the Gene
Ontology [23] (including GOMF, GOBP, and GOCC). Others
were medical subject headings (MeSH) or product use/class
fields from the compounds’ material safety data sheets. There
were also a small number of protein targets (Entrez GeneIDs)
among the annotations.
The annotation terms had been “slimmed,” replacing
excessively detailed terms with more general terms that give a
broader overview. The GO annotations were slimmed using
GO slim [23], whereas MeSH and product use/class terms
were slimmed by manual inspection. The protein targets were
slimmed by assigning the appropriate GOMF, then applying
GO slim.
Finding term-enriched clusters
We identified clusters and scored them for enrichment for
annotation terms as follows.
1 Computed a profile for each of the 7680 samples (20 plates
with 384 wells per plate) by averaging each CellProfiler-
generated feature across the cells in the well. Averaging has
been effective for profiling even though it does not explicitly
model heterogeneity among cells [4,10]. The entire CellProfiler
feature set was used for the analysis; while feature reduction
techniques may result in incremental improvements in
performance, we chose to transform the data as little as
possible in order to focus the evaluation on the assay itself
rather than advanced data-analysis methods. For the same
reason, we also chose well-known and transparent methods for
the subsequent steps of the analysis.
2 Aggregated the 7680 per-sample profiles into 1601 per-
compound profiles by computing the element-wise median. The
1601 per-compound profiles include the median mock profile,
i.e., the median profile of all DMSO-treated samples.
3 Excluded compounds that were inactive in the assay.
Compounds were deemed to be active if their profiles’
Euclidean distance to the median mock profile was above a
cutoff. The cutoff was the 95th percentile of the distances from
the mock-treated wells to the median mock profile. Of the 1600
compounds, 203 (13%) were active.
4 Excluded compounds that were unannotated. Of the 203
active compounds, 75 were annotated by one or more of 96
slimmed terms (Table S7).
5 Performed hierarchical clustering of the compound profiles of
the 75 compounds that were active and annotated, using the
cosine distance and single linkage.
6 Assessed whether each possible cluster is enriched by each
annotation term (Table S8). There were 74 possible clusters,
one for each non-leaf subtree of the dendrogram produced by
the hierarchical clustering. The assessment was by
permutation testing: we measured the fraction of random
clusters of the same size that had at least the same number of
compounds annotated with the term in question. When
constructing random clusters for permutation testing, the
cluster members were drawn from a uniform distribution over
the compounds. It was not necessary to correct for multiple
testing because the fractions were only used for ranking and
not interpreted as p-values. Enrichment in GO terms has also
recently been used to validate clusters of profiles generated
from HTS experiments [24]. Table S8 shows the clusters
ranked by permutation-testing score, i.e., the fraction of
random clusters that had at least the same number of
compounds annotated with the term in question. For each
A Novel Profiling Assay to Measure Cellular States
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cluster, it shows the number of compounds in the cluster, the
number of times the enriched term occurs in the cluster, and
the number of times the enriched term occurs in the entire
dataset. For each compound in the cluster, the table shows
whether the compound has the enriched term, as well as the
compound’s name and Broad ID (internal identifier from our
compound-management department).
Reproducibility
We provide (Text S1) the complete image set, the
CellProfiler pipelines used to identify and measure the cells,
the database of cellular features, and the source code for the
programs that analyze the features and produce the figures
and tables in this article.
Supporting Information
Dataset S1.  CellProfiler pipelines.
(ZIP)
Dataset S2.  CellProfiler illumination function.
(ZIP)
Dataset S3.  Image features extracted by CellProfiler.
(DOCX)
Dataset S4.  Source code to programs that analyze image
features.
(ZIP)
Figure S1.  The cell-painting protocol was developed on
U2OS cells, but it is readily transferable to multiple
adherent cell lines, viz. 3T3 fibroblasts, A549
adenocarcinomic human alveolar basal epithelial cells,
HTB-9 human bladder carcinoma cell, and MCF-7 breast
cancer cells.
Scale bars 50 µm.
(TIF)
Figure S2.  The plate-to-plate variability in the experiment
is small (< 0.2) for the vast majority of features.
The histogram shows the distribution of coefficients of variation
(absolute value) across the features. Each coefficient was
computed across 12 values of the relevant feature: the average
across the mock-treated cells on each of the 12 plates in the
experiment.
(PDF)
Figure S3.  The well-to-well variability in the experiment is
small (< 0.2) for the vast majority of features.
The histogram shows the distribution of coefficients of variation
(absolute value) across the features. Each coefficient was
computed across the 64 well positions in which mock-treated
cells appear on each plate in the experiment.
(PDF)
Figure S4.  The magnitude of the compounds’ effects on
the features. The histogram shows the distribution of maximal
values of the features across the 75 active compounds in the
experiment, standardized by reference to the population of
mock-treated cells on the same plate.
(PDF)
Table S1.  The 1600 bioactive compounds profiled using
our assay.
(DOCX)
Table S2.  Image features measured for each cell by
CellProfiler (see the CellProfiler manual for descriptions of
each feature).
(DOC)
Table S3.  Features ranked by plate-to-plate coefficient of
variation (absolute), limited to mock-treated cells.
(DOCX)
Table S4.  Features ranked by well-to-well coefficient of
variation (absolute), limited to mock-treated cells.
(DOCX)
Table S5.  Features ranked by maximal value across the
compounds.
(DOCX)
Table S6.  Compounds that were annotated.
(DOCX)
Table S7.  The compounds that were both active and
annotated.
(DOCX)
Table S8.  The clusters of compounds most highly
enriched for annotation terms.
(DOCX)
Text S1.  Data and software.
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Text S2.  Cytotoxicity.
(DOC)
Acknowledgements
We thank Thomas P Hasaka for technical assistance, Cindy
Hon for project management, Bridget Wagner for providing the
U2OS cells, and Mathias Wawer for assistance with presenting
chemical structures.
Author Contributions
Conceived and designed the experiments: SLS TRG PAC AEC
AFS SMG VL KLS. Performed the experiments: SMG MMK
KLS. Analyzed the data: VL JAW HAC SMG PAC AEC AFS.
A Novel Profiling Assay to Measure Cellular States
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e80999
Contributed reagents/materials/analysis tools: SMG KLS VL
DW MMK KLS HAC KPS. Wrote the manuscript: SMG VL PAC
AEC AFS.
References
1. Stegmaier K, Wong JS, Ross KN, Chow KT, Peck D et al. (2007)
Signature-based small molecule screening identifies cytosine
arabinoside as an EWS/FLI modulator in Ewing sarcoma. PLoS Med 4:
e122. doi:10.1371/journal.pmed.0040122. PubMed: 17425403.
2. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC et al. (2006) The
Connectivity Map: using gene-expression signatures to connect small
molecules, genes, and disease. Science 313: 1929-1935. doi:10.1126/
science.1132939. PubMed: 17008526.
3. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL et al.
(2005) Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A
102: 15545-15550. doi:10.1073/pnas.0506580102. PubMed:
16199517.
4. Adams CL, Kutsyy V, Coleman DA, Cong G, Crompton AM et al.
(2006) Compound classification using image-based cellular
phenotypes. Methods Enzymol 414: 440-468. doi:10.1016/
S0076-6879(06)14024-0. PubMed: 17110206.
5. Tanaka M, Bateman R, Rauh D, Vaisberg E, Ramachandani S et al.
(2005) An unbiased cell morphology-based screen for new, biologically
active small molecules. PLoS Biol 3: e128. doi:10.1371/journal.pbio.
0030128. PubMed: 15799708.
6. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH et al.
(2006) CellProfiler: image analysis software for identifying and
quantifying cell phenotypes. Genome Biol 7: R100. doi:10.1186/
gb-2006-7-10-r100. PubMed: 17076895.
7. Jones TR, Carpenter AE, Lamprecht MR, Moffat J, Silver SJ et al.
(2009) Scoring diverse cellular morphologies in image-based screens
with iterative feedback and machine learning. Proc Natl Acad Sci U S A
106: 1826-1831. doi:10.1073/pnas.0808843106. PubMed: 19188593.
8. Feng Y, Mitchison TJ, Bender A, Young DW, Tallarico JA (2009) Multi-
parameter phenotypic profiling: using cellular effects to characterize
small-molecule compounds. Nat Rev Drug Discov 8: 567-578. doi:
10.1038/nrd2876. PubMed: 19568283.
9. Futamura Y, Kawatani M, Kazami S, Tanaka K, Muroi M et al. (2012)
Morphobase, an encyclopedic cell morphology database, and its use
for drug target identification. Chem Biol 19: 1620-1630. PubMed:
23261605.
10. Ljosa V, Caie PD, Ter Horst R, Sokolnicki KL, Jenkins EL et al. (.
(2013)) Comparison of methods for image-based profiling of cellular
morphological responses to small-molecule treatment. Nature Methods,
18: 1321–9. PubMed: 24045582.
11. Loo L-H, Wu LF, Altschuler SJ (2007) Image-based multivariate
profiling of drug responses from single cells. Nat Methods 4: 445-453.
PubMed: 17401369.
12. Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF et al. (2004)
Multidimensional drug profiling by automated microscopy. Science 306:
1194-1198. doi:10.1126/science.1100709. PubMed: 15539606.
13. Young DW, Bender A, Hoyt J, McWhinnie E, Chirn G-W et al. (2008)
Integrating high-content screening and ligand-target prediction to
identify mechanism of action. Nat Chem Biol 4: 59-68. doi:10.1038/
nchembio.2007.53. PubMed: 18066055.
14. Roberts JR, Allison DC, Donehower RC, Rowinsky EK (1990)
Development of Polyploidization in Taxol-resistant Human Leukemia
Cells in Vitro. Cancer Res 50: 710-716. PubMed: 1967550.
15. Yvon AM, Wadsworth P, Jordan MA (1999) Taxol suppresses
dynamics of individual microtubules in living human tumor cells. Mol
Biol Cell 10: 947-959. doi:10.1091/mbc.10.4.947. PubMed: 10198049.
16. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak
C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011)
DrugBank 3.0: a comprehensive resource for 'omics' research on
drugs. Nucleic Acids Res 39: D1035-1041
17. Marceau F, Bawolak M-T, Lodge R, Bouthillier J, Gagné-Henley A et al.
(2012) Cation trapping by cellular acidic compartments: beyond the
concept of lysosomotropic drugs. Toxicol Appl Pharmacol 259: 1-12.
doi:10.1016/j.taap.2011.12.004. PubMed: 22198553.
18. Badr CE, Wurdinger T, Nilsson J, Niers JM, Whalen M et al. (2011)
Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-
related apoptosis-inducing ligand and induces an alternative cell death
pathway. Neuro-Oncology 13: 1213-1224. doi:10.1093/neuonc/nor067.
PubMed: 21757445.
19. Riganti C, Campia I, Kopecka J, Gazzano E, Doublier S et al. (2011)
Pleiotropic Effects of Cardioactive Glycosides. Curr Med Chem 18:
872-885. doi:10.2174/092986711794927685. PubMed: 21182478.
20. Ljosa V, Carpenter A (2009) Introduction to the Quantitative Analysis of
Two-Dimensional Fluorescence Microscopy Images for Cell-Based.
Screening - PLOS Comput Biol 5: e1000603.
21. Li F, Yin Z, Jin G, Zhao H, Wong S (2013) Bioimage Informatics for
Systems Pharmacology chapter 17. PLOS Comput Biol 9: e1003043
22. Seiler KP, Ga George, Happ MP, Bodycombe NE, Carrinski Ha et al.
(2008) ChemBank: a small-molecule screening and cheminformatics
resource database. Nucleic Acids Res 36: D351-D359. PubMed:
17947324.
23. Ma Harris, Clark J, Ireland a, Lomax J, Ashburner M, et al. (2004) The
Gene Ontology (GO) database and informatics resource. Nucleic acids
research 32: D258-261
24. Petrone PM, Simms B, Nigsch F, Lounkine E, Kutchukian P et al.
(2012) Rethinking molecular similarity: comparing compounds on the
basis of biological activity. ACS Chem Biol 7: 1399-1409. doi:10.1021/
cb3001028. PubMed: 22594495.
A Novel Profiling Assay to Measure Cellular States
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e80999
